Maria Koehler - 20 Dec 2022 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role: EVP, Chief Medical Officer
Signature: /s/ Steve Forte, Attorney-in-Fact
Issuer symbol: RPTX
Transactions as of: 20 Dec 2022
Net transactions value: +$100,040
Form type: 4
Filing time: 20 Dec 2022, 19:05:37 UTC
Previous filing: 13 Jun 2022
Next filing: 01 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPTX	Common Shares	Options Exercise	$99,916	+48,456	+48%	$2.06^*	149,462	20 Dec 2022	Direct
transaction	RPTX	Common Shares	Options Exercise	$124	+51	+0.03%	$2.42^*	149,513	20 Dec 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RPTX	Employee Stock Option (right to buy)	Options Exercise	$0	-48,456	-52%	$0.000000	44,419	20 Dec 2022	Common Shares	48,456	$2.06	Direct	F1
transaction	RPTX	Employee Stock Option (right to buy)	Options Exercise	$0	-51	-0.05%	$0.000000	111,247	20 Dec 2022	Common Shares	51	$2.42	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty-five percent (25%) of the shares subject to the option vested on May 1, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
F2	Twenty-five percent (25%) of the shares subject to the option vested on December 16, 2020, and one thirty-ninth (1/39th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.